← Evidence map

ReviewFrontiers in pharmacology2016

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation.

Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27597829